Logaraj Kanthasamy
About Logaraj Kanthasamy
Logaraj Kanthasamy is the Director of Global CoE for Clinical and Commercial Business Intelligence at Insmed Incorporated, where he has worked since 2021. He has extensive experience in various industries and specializes in business intelligence and data management for biotech companies.
Work at Insmed
Logaraj Kanthasamy has been serving as the Director of Global CoE | Clinical, Commercial Business Intelligence at Insmed Incorporated since 2021. In this role, he focuses on integrating clinical and commercial business intelligence strategies to support the company’s objectives. Prior to this position, he worked as Associate Director, BI & DW at Insmed from 2018 to 2020. His tenure at Insmed reflects his commitment to advancing the company's data-driven decision-making processes.
Education and Expertise
Logaraj Kanthasamy holds a Bachelor of Engineering (B.E.) in Computer Science and Engineering from National Engineering College. He possesses expertise in implementing custom data marts and data warehouses, particularly for rare disease biotech companies. His technical proficiency includes managing systems using platforms such as Veeva Nitro, Salesforce Health Cloud, and AWS, as well as utilizing business intelligence tools like Qlik, PowerBI, Tableau, and SAP Business Objects.
Background
Logaraj Kanthasamy has a diverse professional background spanning multiple industries, including telecommunications, semiconductor manufacturing, and financial services. He has held various roles throughout his career, including positions at Actavis (now Allergan) as Project Manager & BI Solutions Architect, and at Forest Laboratories as Lead System Analyst - Business Intelligence. His experience also includes working at Hewlett-Packard and Agilent Technologies, where he contributed to business intelligence and data warehousing initiatives.
Achievements
Throughout his career, Logaraj Kanthasamy has demonstrated the ability to lead cross-functional teams in executing high-risk projects, particularly during major re-engineering initiatives and integrations resulting from mergers. He serves as the organizational subject matter expert for technology landscape planning, ensuring alignment with corporate growth goals. His comprehensive understanding of best practices in design, architecture, and implementation within the pharmaceutical and healthcare sectors has contributed to his success in various roles.